
    
      This is a prospective, Post-market, Randomized, Examiner-Only Masked multi-center study to
      evaluate whether clinical parameters for Puros Dermis are at minimum, equivalent when
      compared to Alloderm, the current industry standard for the treatment of single, non-adjacent
      Miller's Class I or II gingival recession.
    
  